• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » ERT named preferred provider for key quality of life assessments

ERT named preferred provider for key quality of life assessments

February 21, 2014
CenterWatch Staff

ERT, a global solution provider for high-quality patient safety and efficacy endpoint data collection, has been named a preferred provider for the administration of the EuroQol Group’s EQ-5D patient reported outcome (PRO) assessment. Specifically, VIAPhone, ERT’s Interactive Voice Response (IVR) system, has been approved to capture both the EQ-5D-3L and the EQ-5D-5L versions of the quality of life assessment. 

The EQ-5D is a commonly used, standardized instrument for measuring health outcomes during the clinical development of new medical products.  Both the EQ-5D-3L and EQ-5D-5L versions address health-related quality of life on the same five dimensions—mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Users of the EQ-5D-3L can choose from three levels of severity, whereas users of the EQ-5D-5L can choose from five different severity levels. 

The EuroQol Group—the copyright owner of the scale—awarded preferred provider status to ERT based on ERT’s established process for ensuring compliant and high-quality electronic implementations of this scale.

“We are pleased that ERT can now offer its customers a reliable option for capturing important health outcomes information via IVR administration of the EQ-5D,” said Gerben Bakker, User Support Officer, EuroQol Group. “This offering will enable biopharmaceutical researchers to evaluate whether patients’ health states are impacted by new medical treatments.”

VIAPhone is one of ERT’s multiple electronic solutions that improve the collection of clinical outcome assessment (COA) data in clinical research. VIAPhone offers significant advantages over paper-and-pencil administration of the scale, including improvements in patient compliance, data quality and increased trial efficiencies.

“Being named a preferred provider verifies that the scientific foundation upon which our electronic COA solutions are built meets the high standards set by EuroQol,” said Bob Young, executive vice president, COA Solutions, ERT. 

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing